EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer

Jussi Nikkola, Lauri Ryyppö, Juuso Vuorinen, Lauri Moilanen, Maarit Ahtiainen, Kirsi Pylvänäinen, Hanna Selin, Tuomo Virtanen, Matti Nykter, Thea Veitonmäki, Jukka-Pekka Mecklin, Toni T Seppälä und 1 weitere

Cell Reports · 2025

DOI: 10.1016/j.celrep.2025.116388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Jussi Nikkola und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland; Department of Urology, Tampere University Hos…. Hauptthemen laut MEDLINE: Telomerase, Colorectal Neoplasms, Hereditary Nonpolyposis, Promoter Regions, Genetic, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseColorectal Neoplasms, Hereditary NonpolyposisPromoter Regions, GeneticMutationUrologic NeoplasmsUrotheliumHumansMicrosatellite InstabilityFemaleMaleDNA-Binding ProteinsMiddle AgedAgedTranscription FactorsReceptor, Fibroblast Growth Factor, Type 3Neoplasm Proteins

Stichwörter der Autor:innen

CP: CancerCP: GenomicsDNA mismatch repairLynch syndromehypermutationtelomeraseurothelial cancer

Substanzen

TelomeraseTERT protein, humanDNA-Binding ProteinsTranscription FactorsARID1A protein, humanReceptor, Fibroblast Growth Factor, Type 3Neoplasm ProteinsKMT2D protein, humanFGFR3 protein, human

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland; Department of Urology, Tampere University Hospital, Tampere, Finland. Electronic address: jussi.nikkola@fimnet.fi.
  • Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.
  • Department of Pathology, Hospital Nova of Central Finland, Jyväskylä, Finland.
  • Department of Education and Research, The Wellbeing Services County of Central Finland, Jyväskylä, Finland.
  • Department of Urology, Tampere University Hospital, Tampere, Finland.
  • Department of Education and Research, The Wellbeing Services County of Central Finland, Jyväskylä, Finland; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.

Zitieren

APA

Nikkola, J., Ryyppö, L., Vuorinen, J., Moilanen, L., Ahtiainen, M., Pylvänäinen, K., Selin, H., Virtanen, T., Nykter, M., Veitonmäki, T., Mecklin, J. P., Seppälä, T. T., & Annala, M. (2025). Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116388

Vancouver

Nikkola J, Ryyppö L, Vuorinen J, Moilanen L, Ahtiainen M, Pylvänäinen K, et al. Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116388

BibTeX
@article{Nikkola2025,
  author = {Nikkola, Jussi and Ryyppö, Lauri and Vuorinen, Juuso and Moilanen, Lauri and Ahtiainen, Maarit and Pylvänäinen, Kirsi and Selin, Hanna and Virtanen, Tuomo and Nykter, Matti and Veitonmäki, Thea and Mecklin, Jukka-Pekka and Seppälä, Toni T and Annala, Matti},
  title = {Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer},
  journal = {Cell Reports},
  year = {2025},
  doi = {10.1016/j.celrep.2025.116388}
}
Kostenlos starten →